First Personal Financial Services Rigel Pharmaceuticals Inc Transaction History

First Personal Financial Services

  • $441 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 07, 2018
SELL
$2.83 - $4.11 $2,688 - $3,904
-950 Closed
0 $0
Q1 2018

May 10, 2018
SELL
$3.54 - $4.54 $2,301 - $2,951
-650 Reduced 40.63%
950 $3,000
Q4 2017

Jan 25, 2018
BUY
$3.23 - $4.3 $5,168 - $6,880
1,600
1,600 $6,000

Others Institutions Holding RIGL

# of Institutions
13
Shares Held
355K
Call Options Held
0
Put Options Held
0
View Full List

About RIGEL PHARMACEUTICALS INC

RIGL Quotes by TradingView
  • Ticker RIGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 172,836,000
  • Market Cap $2.32B
  • Description
  • Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...
More about RIGL
Track This Portfolio

Track First Personal Financial Services Portfolio

Follow First Personal Financial Services and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Personal Financial Services, based on Form 13F filings with the SEC.

News

Stay updated on First Personal Financial Services with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email